LMY-922
/ Luminary Therap
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
July 29, 2026
BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Autoimmune Disease
(clinicaltrials.gov)
- P1 | N=94 | Not yet recruiting | Sponsor: Luminary Therapeutics
New P1 trial • Dermatomyositis • Immunology • Inflammatory Arthritis • Lupus • Myositis • Rheumatoid Arthritis • Rheumatology • Scleroderma • Systemic Lupus Erythematosus • Systemic Sclerosis • IFIH1 • TRIM33
July 02, 2026
BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Hematologic Malignancies
(clinicaltrials.gov)
- P1 | N=27 | Not yet recruiting | Sponsor: Luminary Therapeutics
New P1 trial • B Cell Lymphoma • Chronic Lymphocytic Leukemia • Follicular Lymphoma • Hairy Cell Leukemia • Hematological Malignancies • Leukemia • Lymphoma • Multiple Myeloma • Non-Hodgkin’s Lymphoma • Oncology • BCL2
1 to 2
Of
2
Go to page
1